Outcomes of Adjuvant Chemoradiation and Predictors of Survival After Extended Cholecystectomy in Gall Bladder Carcinoma: a Single Institution Experience from an Endemic Region

Journal of Gastrointestinal Cancer

Volumn 46, Issue 1, 2015, Pages 48-53

  Agrawal, S ^a   Gupta, P K ^a   Rastogi, N ^a   Lawrence, A ^a   Kumari, N ^a   Das, K J Maria ^a   Saxena, R ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Adjuvant chemoradiation; Extended cholecystectomy; Gall bladder cancer

Indexed keywords

FLUOROURACIL;

ADJUVANT CHEMORADIOTHERAPY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SURVIVAL; CHEMOTHERAPY INDUCED EMESIS; CHOLECYSTECTOMY; CLINICAL ARTICLE; CONSOLIDATION CHEMOTHERAPY; DIARRHEA; DISEASE FREE SURVIVAL; DISTANT METASTASIS; DRUG DOSE REDUCTION; EXTENDED CHOLECYSTECTOMY; FEMALE; FOLLOW UP; GALLBLADDER CARCINOMA; HUMAN; INCISIONAL HERNIA; INDIA; INTESTINE OBSTRUCTION; LYMPH NODE METASTASIS; LYMPH VESSEL METASTASIS; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION INJURY; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT OUTCOME; TUMOR DIFFERENTIATION; ENDEMIC DISEASE; EPIDEMIOLOGY; GALLBLADDER NEOPLASMS; MIDDLE AGED; MORTALITY; PROCEDURES; PROGNOSIS; SURVIVAL;

ADULT; AGED; CHEMORADIOTHERAPY, ADJUVANT; CHOLECYSTECTOMY; DISEASE-FREE SURVIVAL; ENDEMIC DISEASES; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; INDIA; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS;

EID: 84925490119     PISSN: 19416628     EISSN: 19416636     Source Type: Journal    
DOI: 10.1007/s12029-014-9676-x     Document Type: Article

References (19)

1. Randi G, Franceschi S, La Vecchia C. Gallbladder cancer worldwide: geographical distribution and risk factors. Int J Cancer. 2006;118:1591–602.
2. Jarnagin WR, Ruo L, Little SA, et al. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer. 2003;98:1689–700.
3. Study Group of Surgical Adjuvant Therapy for Carcinomas of the Pancreas and Biliary Tract, Tadahiro T, Hodaka A, Hideki Y, Yuji N, Takashi M, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002;95:1685–95.
4. Horgan AM, Eitan A, Thomas W, Knox JJ. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol. 2012;30(16):1934–40.
5. Kim WS, Choi DW, You DD, Han S-S, Kim Y-K, Lee K-W, et al. Risk factors influencing recurrence, patterns of recurrence, and the efficacy of adjuvant therapy after radical resection for gallbladder carcinoma. J Gastrointest Surg. 2010;14:679–87.
6. Mahantshetty UM, Palled SR, Engineer R, Homkar G, Shrivastava SK, Shukla PJ. Adjuvant radiation therapy in gallbladder cancers: 10 years experience at Tata Memorial Hospital. J Cancer Res Ther. 2006;2:52–6.
7. Yoshioka Y, Ogawa K, Oikawa H, Onishi H, Uchida N, Maebayashi T. Factors influencing survival outcome for radiotherapy for biliary tract cancer: a multicenter retrospective study. Radiother Oncol. 2014;110:546–52.
8. Howlader N, Noone AM, Krapcho M, et al.: SEER cancer statistics review, 1975–2008, National Cancer Institute. http://seer.cancer.gov/csr/1975_2008
9. de Groen PC, Gores GJ, LaRusso NF. Biliary tract cancers. N Engl J Med. 1999;341:1368–78.
10. Wagholikar GD, Behari A, Krishnani N. Early gallbladder cancer. J Am Coll Surg. 2002;194:137–41.
11. Ogura Y, Tabata M, Kawarada Y, Mizumoto R. Effect of hepatic invasion on the choice of hepatic resection for advanced carcinoma of the gallbladder: histologic analysis of 32 surgical cases. World J Surg. 1998;22:262–7.
12. Yamaguchi K, Chijiwa K, Shimizi S. Anatomical limit of extended cholecystectomy for gallbladder carcinoma involving the neck of the gallbladder. Int Surg. 1998;83:21–3.
13. Todoraki T, Kawamoto T, Takahashi H, Takada Y, Koike N, Otsuka M, et al. Treatment of gallbladder carcinoma by radical resection. Br J Surg. 1999;86:622–7.
14. Gold DG, Miller RC, Haddock MG, Gunderson LL, Quevedo F, Donohue JH, et al. Adjuvant therapy for gallbladder carcinoma. The mayo clinic experience. Int J Radiation Oncology Biol Phys. 2009;75(1):150–5.
15. Müller B, Sola JA, Carcamo M, Ciudad AM, Trujillo C, Cerda B. Adjuvant chemoradiation for resected gallbladder cancer: treatment strategies for one of the leading causes of cancer death in Chilean women. Indian J Cancer. 2013;50:184–8.
16. González ME, Giannini OH, González P, Saldaña B. Adjuvant radio-chemotherapy after extended or simple cholecystectomy in gallbladder cancer. Clin Transl Oncol. 2011;13:480–4.
17. Lim KH, Oh DY, Chie EK, Im SA, Kim TY, et al. Adjuvant concurrent chemoradiation therapy (CCRT) alone versus CCRT followed by adjuvant chemotherapy: which is better in patients with radically resected extrahepatic biliary tract cancer? A nonrandomized, single center study. BMC Cancer. 2009;9:345.
18. Todoraki T, Kawamoto T, Otsuka M, Koike N, Yoshida S, Takada Y. Benefits of combining radiotherapy with aggressive resection for stage IV gallbladder cancer. Hepatogastroenterology. 1999;46:1585–91.
19. Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? Cancer. 2002;95:1685–95.